AU
UK
CA
NZ
IND
US
A Drug That Worked Once, and Then Did Not
ARevenueBeat That Moved the Market
A Clinical Milestone in One of Oncology's Toughest Indications
A Compounding Crisis
Key Highlights
AIDemandDrives RecordRevenueGrowth
StrongRevenueExpansion Led by Scores Segment Growth
RevenueGrowth Driven by M&A and FX, Organic Trends Mixed
ONEOK Q1 2026EarningsAnalysis:Volume-Led Growth Across Core Segments
RevenueGrowth Driven byVolumeRecovery and International Strength
Please wait processing your request...